Acta Medica Lituanica最新文献

筛选
英文 中文
A Rare Sigmoid-Colon Schwannoma in a Premenopausal Woman: A Case Report 绝经前妇女罕见乙状结肠神经鞘瘤1例报告
Acta Medica Lituanica Pub Date : 2023-10-18 DOI: 10.15388/amed.2023.30.2.11
Aikaterini Selntigia, Benedetto Neri, Consuelo Russo, Francesco Giuseppe Martire, Giorgia Soreca, Dario Biasutto, Francesco Maria Di Matteo, Caterina Exacoustos
{"title":"A Rare Sigmoid-Colon Schwannoma in a Premenopausal Woman: A Case Report","authors":"Aikaterini Selntigia, Benedetto Neri, Consuelo Russo, Francesco Giuseppe Martire, Giorgia Soreca, Dario Biasutto, Francesco Maria Di Matteo, Caterina Exacoustos","doi":"10.15388/amed.2023.30.2.11","DOIUrl":"https://doi.org/10.15388/amed.2023.30.2.11","url":null,"abstract":"Background. Schwannomas of the gastrointestinal tract are a rare type of spindle cell tumor of peripheral nerve. Commonly, schwannomas are discovered incidentally, as they are usually asymptomatic.Case. 46-year-old female patient, suffering from secondary amenorrhea and nonspecific intermittent pelvic pain associated with constipation. During gynecological visit an ultrasonographic systematic transvaginal examination was performed. At the sigmoid-rectal level an intraluminal solid mass was described and an urgent colonoscopy was prescribed. Endoscopic submucosal dissection was performed with en-bloc resection. On immunohistochemical analysis, S100 was strongly positive in tumor cells. Finally, a benign schwannoma of the sigmoid colon was diagnosed.Conclusion. Our case highlights the importance of an adequate transvaginal pelvic examination with the evaluation of all pelvic organs. It could be challenging to make diagnosis in an early stage on asymptomatic patients.","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135884550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Unique Type or Variation of Bile Duct Cyst in a 9-Year-Old Girl:A Remarkable Case Study 一种独特类型或变异的胆管囊肿在一个9岁女孩:一个值得注意的案例研究
Acta Medica Lituanica Pub Date : 2023-10-09 DOI: 10.15388/amed.2023.30.2.3
Aleksandra Paņina, Astra Zviedre, Paulis Laizāns, Ilze Apine
{"title":"A Unique Type or Variation of Bile Duct Cyst in a 9-Year-Old Girl:A Remarkable Case Study","authors":"Aleksandra Paņina, Astra Zviedre, Paulis Laizāns, Ilze Apine","doi":"10.15388/amed.2023.30.2.3","DOIUrl":"https://doi.org/10.15388/amed.2023.30.2.3","url":null,"abstract":"Patients with bile duct cysts require careful radiological assessment of the hepatobiliary system prior to surgical intervention. This clinical case is uncommon with an atypical clinical presentation and radiological findings. According to the most widely used classification of choledochal cysts, this case presents a combination of Type I and Type IV of choledochal cyst (CC) combining the form of extra, intrahepatic bile ducts and cystic duct dilations.","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"119 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135141593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Incidence of Iliopsoas Tendinopathy and Labral Tears on High Resolution MRI, An Observational Study 高分辨率MRI对髂腰肌肌腱病变和唇部撕裂发生率的观察研究
Acta Medica Lituanica Pub Date : 2023-07-31 DOI: 10.15388/amed.2023.30.2.2
Ahmed Saad, Roger Chan, Aamer Iqbal, Mark Davies, Steven James, Rajesh Botchu
{"title":"The Incidence of Iliopsoas Tendinopathy and Labral Tears on High Resolution MRI, An Observational Study","authors":"Ahmed Saad, Roger Chan, Aamer Iqbal, Mark Davies, Steven James, Rajesh Botchu","doi":"10.15388/amed.2023.30.2.2","DOIUrl":"https://doi.org/10.15388/amed.2023.30.2.2","url":null,"abstract":"Introduction. Labral tears (LT) can present with hip or groin pain. Investigation of LT is typically with Magnetic Resonance Arthrography (MRA). The injection of contrast for MRA can lead to fluid signal intensity/oedema on fluid sensitive sequences within the iliopsoas muscle and tendon complex masking the diagnosis of iliopsoas tendinopathy, which may present with similar symptoms. The aim of this study was to identify the presence of iliopsoas oedema in young adult patients being investigated for LT.Material and methods. We performed a retrospective search of our radiology system for the word ‘labral tear’ in the reports of patients who had MRI between 2012 to 2018. Patients under the age of 40 years who underwent high resolution dedicated hip MRI were included in our study. From this database, we then used a keyword search ‘strain and (o)edema’ to identify cases of iliopsoas pathology and analysed the results. Results. We identified 1151 consecutive cases of high resolution hip MRI with a suspected labral tear. 503 patients under the age of 40 years were included in our study with the average age of 27 years. Of the 503 patients within our cohort, searching for the word ‘strain’ identified 48 (9.5%) cases. Of these, 26 (5.3%) patients had iliopsoas oedema with a labral tear. 22 (4.4%) patients had iliopsoas oedema without a labral tear. Conclusion. Our study shows that 4.4% of patients undergoing MRA have no labral tears but iliopsoas oedema. Patients should undergo MRI to exclude iliopsoas strains before MRA.","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135314923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current and Perspective Approaches to the Treatment of Prolactinomas 治疗泌乳素瘤的现有方法和前瞻性方法
Acta Medica Lituanica Pub Date : 2023-07-31 DOI: 10.15388/amed.2023.30.2.1
N. Barabash, Tetiana Tykhonova, Olena Kanishcheva
{"title":"Current and Perspective Approaches to the Treatment of Prolactinomas","authors":"N. Barabash, Tetiana Tykhonova, Olena Kanishcheva","doi":"10.15388/amed.2023.30.2.1","DOIUrl":"https://doi.org/10.15388/amed.2023.30.2.1","url":null,"abstract":"Background: Along with the presence of the 2011 Endocrine Society Clinical Practice Guidelines and numerous large-scale studies on the treatment of hyperprolactinemia of different origin, there are some unresolved questions, ambiguous and sometimes contradictory points of view regarding the management of patients with prolactinomas. This overview is devoted to the analysis of the results of modern clinical studies and the approaches towards the management of hyperprolactinemia caused by prolactinoma.Materials and methods: A systematic research of the literature for the appropriate keywords published mainly for the last 10 years was done; also, a reference list of each selected article was analysed. We included to our review the articles reporting controversial issues or new data on the treatment of hyperprolactinemia.Results: The review describes various problems arising during the treatment of prolactinoma. The presence of primary and secondary dopamine agonist resistance in each case requires an individual approach, and sometimes may include the use of the antineoplastic agent temozolomide. The side effects of dopamine agonists are discussed, with quite rare ones, including valvulopathy, pathological psychological conditions and cerebrospinal rhinorrhea. The controversial issue of the duration and doses of the drug used to achieve a lasting effect in the treatment of prolactinomas is considered. There are some points connected with the frequency of relapses. Thus, recurrence is correlated to the duration of treatment with dopamine agonists, prolactin levels at diagnosis, and the initial tumor size. Metformin, somatostatin analogues, selective estrogen receptor modulators, tyrosine kinase inhibitors, inhibitors of the mammalian target of rapamycin, epidermal growth factor receptor antagonists are investigated nowadays as potential alternative methods of drug treatment of prolactinomas. Conclusion: Drug therapy with dopamine agonists makes it possible to achieve the desired results in the vast majority of patients. However, despite the proven safety of this group of medicines, the risk of side effects should still be taken into account. The therapy regimen should be determined by the clinical course of prolactinoma and the patient’s response to treatment. Other options of treatment should be considered in patients intolerant to medical therapy, with contraindication or resistance to dopamine agonists, in the case of a malignant tumor. The presence of refractory to any of the applied methods of treatment and aggressive prolactinomas leads to the search for new drugs.","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139353526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous Thrombin Injection with Balloon Protection for a Large Iatrogenic Femoral Artery Pseudoaneurysm: A Case Report with Review of Literature. 经皮注射凝血酶球囊保护治疗医源性股动脉假性动脉瘤1例并文献复习。
Acta Medica Lituanica Pub Date : 2023-01-01 DOI: 10.15388/Amed.2023.30.1.9
Ranjan Patel, Tara Prasad Tripathy, Ripan Debbarma, Sudipta Mohakud, Satyapriya Mohanty, Nerbadyswari Deep Bag
{"title":"Percutaneous Thrombin Injection with Balloon Protection for a Large Iatrogenic Femoral Artery Pseudoaneurysm: A Case Report with Review of Literature.","authors":"Ranjan Patel,&nbsp;Tara Prasad Tripathy,&nbsp;Ripan Debbarma,&nbsp;Sudipta Mohakud,&nbsp;Satyapriya Mohanty,&nbsp;Nerbadyswari Deep Bag","doi":"10.15388/Amed.2023.30.1.9","DOIUrl":"https://doi.org/10.15388/Amed.2023.30.1.9","url":null,"abstract":"<p><p>Iatrogenic femoral artery pseudoaneurysms (IFAPs) are not uncommon due to the increase in various minimally-invasive endovascular procedures. Percutaneous thrombin injection is an established technique for large pseudoaneurysms. When ultrasound-guided compression of an aneurysmal neck is not feasible, percutaneous thrombin injection can be combined with endovascular balloon occlusion to prevent leakage of thrombin into the parent artery. We describe a large IFAP following the removal of the femoral dialysis catheter after an inadvertent arterial puncture, which was managed with percutaneous ultrasound-guided (USG) thrombin injection with simultaneous balloon occlusion at the level of the aneurysmal neck without any complications. Follow-up imaging showed thrombosed IFAP without any recurrence.</p>","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"30 1","pages":"80-85"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417016/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10000517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solitary Fibrous Tumor of the Peritoneal Cavity and Greater Omentum: Case Report and Review of the Literature. 腹膜腔及大网膜孤立性纤维性肿瘤:病例报告及文献复习。
Acta Medica Lituanica Pub Date : 2023-01-01 DOI: 10.15388/Amed.2023.30.1.7
Neda Gendvilaitė, Dmitrij Šeinin, Laurynas Beržanskas, Tomas Poškus
{"title":"Solitary Fibrous Tumor of the Peritoneal Cavity and Greater Omentum: Case Report and Review of the Literature.","authors":"Neda Gendvilaitė,&nbsp;Dmitrij Šeinin,&nbsp;Laurynas Beržanskas,&nbsp;Tomas Poškus","doi":"10.15388/Amed.2023.30.1.7","DOIUrl":"https://doi.org/10.15388/Amed.2023.30.1.7","url":null,"abstract":"<p><strong>Background: </strong>The solitary fibrous tumor is a rare soft tissue mesenchymal tumor which typically arises from the pleura but may be found anywhere in the body. Abdominal localizations are very rare. The solitary fibrous tumor is classified into two forms, pleural and extrapleural, and morphologically they resemble each other. The diagnostics of the tumor is usually accidental because usually there are no clinical symptoms. The main treatment of the solitary fibrous tumor is the surgical removal of the tumor while radiotherapy treatment and chemotherapy outcomes remain unclear due to the rarity of the tumor and lack of data.</p><p><strong>Case presentation: </strong>We report the case of the 32-year-old man who was diagnosed with the solitary fibrous tumor of the peritoneal cavity. Laparotomy was performed. A grayish-white, stiff, coarse-grained tumor about 11 cm in diameter of the greater omentum was found and radical omentectomy with tumor removal were performed. Postoperative course was uneventful and the patient is well with no signs of recurrence on the CT scan of the chest and abdomen and MRI of the pelvis at 6 months after surgery.</p><p><strong>Conclusions: </strong>The solitary fibrous tumor is a rare condition. It is a borderline-malignant tumor but may cause serious complications if not treated. Due to the absence of clinical symptoms, the tumor is usually detected accidentally. The radical surgical removal of the tumor is the most optimal treatment.</p>","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"30 1","pages":"66-73"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9998482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes of Colorectal Cancer Diagnostics and Hospitalizations during First Wave of COVID-19 Pandemic in Lithuania. 立陶宛第一波COVID-19大流行期间结直肠癌诊断率和住院率的变化
Acta Medica Lituanica Pub Date : 2023-01-01 DOI: 10.15388/Amed.2023.30.1.4
Dignė Jurkevičiūtė, Sandra Mauravičiūtė, Audrius Dulskas, Inga Kildušienė, Eugenijus Stratilatovas, Sonata Jarmalaitė
{"title":"Changes of Colorectal Cancer Diagnostics and Hospitalizations during First Wave of COVID-19 Pandemic in Lithuania.","authors":"Dignė Jurkevičiūtė,&nbsp;Sandra Mauravičiūtė,&nbsp;Audrius Dulskas,&nbsp;Inga Kildušienė,&nbsp;Eugenijus Stratilatovas,&nbsp;Sonata Jarmalaitė","doi":"10.15388/Amed.2023.30.1.4","DOIUrl":"https://doi.org/10.15388/Amed.2023.30.1.4","url":null,"abstract":"<p><strong>Purpose: </strong>Our aim was to see the possible effect of the first COVID pandemic wave in Lithuania on colorectal cancer (CRC) preventive, diagnostic and treatment procedures.</p><p><strong>Methods: </strong>A retrospective analysis was performed using the database of the National Cancer Institute, Lithuania. We have divided patients into two groups: group 1 - patients treated during the nonpandemic period (2019 January 1 to 2019 July 31) and group 2 - the pandemic period (2020 January 1 to 2020 July 31). We analyzed numbers of screening, therapeutic colonoscopies performed, and treated patients for CRC during two periods.</p><p><strong>Results: </strong>In general, 1318 lower gastrointestinal endoscopic procedures were performed in the first group and 862 procedures in the second group, which was 34.6% less compared to the first group. The first group included 672 (51%) colonoscopies, 172 (13%) day surgeries and 474 (36%) CRC screening programmes. In group 2, 456 (34.6%) less patients underwent CRC diagnostics and treatment: 141 (21%) less colonoscopies, 93 (54%) less day surgeries, 222 (47%) less CRC screening programmes, and 26 (13%) less patients were hospitalized for surgical treatment (196 vs 170).</p><p><strong>Conclusion: </strong>Our study reveals worrying changes in the timely access to diagnostic procedures during the COVID-19 pandemic that possibly provoked rise in cases with the advanced stage CRC. However, despite numerical difference between groups existed, the difference between groups do not reach statistical significant level.</p>","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"30 1","pages":"39-44"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10052282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Waning Humoral Response 6 Month after Double Vaccination with the mRNA-BNT162b2 Vaccine in Hemodialysis Patients. 血液透析患者双重接种mRNA-BNT162b2疫苗6个月后体液反应减弱
Acta Medica Lituanica Pub Date : 2023-01-01 DOI: 10.15388/Amed.2023.30.1.3
Vilma Balčiuvienė, Asta Burčiuvienė, Mathias Haarhaus, Jurgita Uogintaitė, Asta Janavičienė, Lina Santockienė, Jurgita Mitrikevičienė, Loreta Aleknienė, Danutė Keinaitė
{"title":"Waning Humoral Response 6 Month after Double Vaccination with the mRNA-BNT162b2 Vaccine in Hemodialysis Patients.","authors":"Vilma Balčiuvienė,&nbsp;Asta Burčiuvienė,&nbsp;Mathias Haarhaus,&nbsp;Jurgita Uogintaitė,&nbsp;Asta Janavičienė,&nbsp;Lina Santockienė,&nbsp;Jurgita Mitrikevičienė,&nbsp;Loreta Aleknienė,&nbsp;Danutė Keinaitė","doi":"10.15388/Amed.2023.30.1.3","DOIUrl":"https://doi.org/10.15388/Amed.2023.30.1.3","url":null,"abstract":"<p><strong>Introduction: </strong>Although most hemodialysis patients (HDP) exhibit an initial seroresponse to vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), studies have shown this response to be lower compared to healthy subjects. This fact raised concerns regarding the durability of the immune response and effective protection against severe Coronavirus disease 2019 (COVID-19) in this vulnerable population. The aim of our study was to evaluate the change in antibody levels over time in HDP population.</p><p><strong>Materials and methods: </strong>We performed a prospective multicenter study, evaluating antibody response among HDP at 2 and at 6 months after complete two-dose vaccination course with the mRNA-BNT162b2 (Pfizer-BioNTech) vaccine. The study was performed in 14 hemodialysis units of a private dialysis provider in Lithuania. The serum samples of 189 HDP were tested for SARS-CoV-2 IgG against the Spike glycoprotein.</p><p><strong>Results: </strong>189 HDP participated in the study. Patients were 64.3±15.7 years of age, 116 (61.4%) were males and 73 (38.6%) were females. Among them, 183 (96.8%) were seropositive for anti-S IgG at 2 months after the second immunization dose. Six months after the second dose only 145 (76.7%) of study participants had positive anti-S IgG titers. The median level of anti-S IgG titers after 2 months was 383.1 BAU/mL (166.2-995.6) and after 6 months this level significantly decreased to 51.4 BAU/mL (22.0-104.0) (p<0.001). Seroresponses at both time points inversely correlated with increasing patient's age. Risk factor for absent response after 2 months included oncologic disease. Systemic autoimmune disease and a history of myocardial infarction increased risk to be seronegative 6 months after the second vaccine dose.</p><p><strong>Conclusions: </strong>The majority of hemodialysis patients seroresponded after BNT162b2/Pfizer vaccination, but vaccine-induced humoral immunity wanes over time.</p>","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"30 1","pages":"26-38"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10413380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eosinophilic Granulomatosis with Polyangiitis in an 8-year-old Girl Manifesting as Hypereosinophilic Syndrome with Myocarditis, Stroke, and Subsequent Orbital Involvement. 8岁女孩嗜酸性肉芽肿病合并多血管炎,表现为嗜酸性粒细胞增多综合征,并发心肌炎、中风和随后的眼眶受累。
Acta Medica Lituanica Pub Date : 2023-01-01 DOI: 10.15388/Amed.2023.30.1.5
Aleksandra Panina, Elīna Ligere, Elīna Aleksejeva, Zane Davidsone, Elizabete Cebure, Irina Erdmane
{"title":"Eosinophilic Granulomatosis with Polyangiitis in an 8-year-old Girl Manifesting as Hypereosinophilic Syndrome with Myocarditis, Stroke, and Subsequent Orbital Involvement.","authors":"Aleksandra Panina,&nbsp;Elīna Ligere,&nbsp;Elīna Aleksejeva,&nbsp;Zane Davidsone,&nbsp;Elizabete Cebure,&nbsp;Irina Erdmane","doi":"10.15388/Amed.2023.30.1.5","DOIUrl":"https://doi.org/10.15388/Amed.2023.30.1.5","url":null,"abstract":"<p><p>Hypereosinophilic syndrome (HES) is a heterogeneous group of disorders characterized by peripheral blood eosinophilia of 1.5 × 10<sup>9</sup>/L (1,500/μL) or greater, with evidence of end-organ damage attributable to eosinophilia (e.g., heart, liver or lung) with no other cause for the end-organ damage [1]. Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disorder that may affect multiple organ systems (lungs, heart, kidneys, or the nervous system). The disorder is characterized by hypereosinophilia in the blood and tissues, inflammation of blood vessels (vasculitis), and the development of inflammatory nodular lesions called granulomatosis [2]. We report a case with a 9-year-old girl presenting with severe hypereosinophilia, ischemic stroke, right-sided hemiparesis and myocarditis treated with methylprednisolone, enoxaparin, rivaroxaban and carvedilol. The patient recovered successfully from myocarditis and stroke but manifested with right-sided orbital involvement as pre- and post-septal orbital cellulitis 10 months later with necrotizing granulomatous perivascular chronic infiltration with eosinophilic infiltration treated with methylprednisolone and subsequent mepolizumab with successful remission of orbital involvement, but severe exogenous Cushing's syndrome and myocardial fibrosis.</p>","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"30 1","pages":"45-52"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417011/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10052277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancreatic Intraductal Papillary Mucinous Neoplasms: A Narrative Review. 胰腺导管内乳头状黏液性肿瘤:叙述回顾。
Acta Medica Lituanica Pub Date : 2023-01-01 DOI: 10.15388/Amed.2023.30.1.6
Daniel Paramythiotis, Eleni Karlafti, Georgia Fotiadou, Maria Charalampidou, Anestis Karakatsanis, Aristeidis Ioannidis, Antonios Michalopoulos
{"title":"Pancreatic Intraductal Papillary Mucinous Neoplasms: A Narrative Review.","authors":"Daniel Paramythiotis,&nbsp;Eleni Karlafti,&nbsp;Georgia Fotiadou,&nbsp;Maria Charalampidou,&nbsp;Anestis Karakatsanis,&nbsp;Aristeidis Ioannidis,&nbsp;Antonios Michalopoulos","doi":"10.15388/Amed.2023.30.1.6","DOIUrl":"https://doi.org/10.15388/Amed.2023.30.1.6","url":null,"abstract":"<p><strong>Introduction: </strong>Intraductal papillary mucinous neoplasms (IPMNs) are the most frequent cystic pancreatic neoplasm. They derive from the main pancreatic duct or branch ducts.</p><p><strong>Aim: </strong>This narrative review aims to present and compare the current guidelines on the management of IPMNs.</p><p><strong>Materials and methods: </strong>We reviewed the most important scientific literature on the management of IPMNs.</p><p><strong>Discussion: </strong>The clinical presentation of IPMNs is usually nonspecific; common symptoms are abdominal pain, weight loss, and jaundice. There are no sex differences, and the incidence increases with age. It is considered a premalignant lesion associated with synchronous or metachronous carcinomas. Multifocal sites within the pancreas and the presence of solid components, like mural nodules, are predictive factors for developing malignancy. Magnetic resonance imaging (MRI) is the imaging technique of choice. However, computed tomography (CT) and endoscopic ultrasound (EUS) with fine-needle aspiration (FNA) can also contribute to the diagnosis. Resection is the optimal treatment for IPMNs that arise from the main duct, while several indications are suggested for the surgery on IPMNs of branch ducts.</p><p><strong>Conclusion: </strong>The decision on surgery is not always a simple task and should be based on high-risk features of the neoplasm. In any case, re-examination and follow-up are highly recommended.</p>","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"30 1","pages":"53-65"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417013/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10052280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信